Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
7.94M
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
7.71M
-
Shares change
-
+133K
-
Total reported value, excl. options
-
$98M
-
Value change
-
+$1.6M
-
Number of buys
-
32
-
Number of sells
-
-9
-
Price
-
$12.71
Significant Holders of X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR) as of Q3 2019
51 filings reported holding XFOR - X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share as of Q3 2019.
X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.71M shares
of 7.94M outstanding shares and own 97.15% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (936K shares), FMR LLC (900K shares), Cormorant Asset Management, LP (882K shares), BlackRock Inc. (707K shares), BVF INC/IL (593K shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (564K shares), VANGUARD GROUP INC (542K shares), RA CAPITAL MANAGEMENT, L.P. (478K shares), NEA Management Company, LLC (333K shares), and Polaris Venture Management Co. V, L.L.C. (311K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.